Project Ronin CEO: AI Reshaping Oncology Decision-Making
Interview with Dave Hodgson, CEO of Project Ronin
Dave Hodgson, the CEO of Project Ronin, shares how AI is transforming oncology decision-making.
Project Ronin, an oncology intelligence platform company, is led by co-founder and CEO Dave Hodgson. The company unites oncologists, patients, and their ecosystems to collect and analyze real-world oncology data. By harnessing the power of machine learning and AI, Project Ronin provides valuable data-driven insights that support oncologists in making informed decisions about patient care.
"AI is fundamentally changing how oncologists make decisions," said Hodgson. "With access to real-time data and artificial intelligence, oncologists can gain a more complete understanding of each patient's unique journey, enabling them to tailor treatments, monitor progress, and improve patient outcomes."
As Project Ronin continues to innovate, its goal remains to revolutionize cancer care through the power of technology. Hodgson believes that the future of cancer care lies in the seamless integration of AI and oncology expertise.
Komentar